Celon Pharma S.A. (WSE:CLN)
Poland flag Poland · Delayed Price · Currency is PLN
22.80
-0.10 (-0.44%)
Oct 6, 2025, 10:34 AM CET

Celon Pharma Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
1,2281,4257897161,6911,825
Upgrade
Market Cap Growth
-23.75%80.47%10.32%-57.68%-7.35%2.14%
Upgrade
Enterprise Value
1,2091,3367045781,4871,807
Upgrade
Last Close Price
22.8026.4515.3813.8732.2039.31
Upgrade
Forward PE
2046.5535.84---63.04
Upgrade
PS Ratio
5.956.933.683.698.6211.59
Upgrade
PB Ratio
3.193.201.771.493.055.30
Upgrade
P/TBV Ratio
3.213.261.831.563.215.96
Upgrade
P/FCF Ratio
----650.25-
Upgrade
P/OCF Ratio
----38.4725.44
Upgrade
EV/Sales Ratio
5.866.503.282.987.5911.48
Upgrade
EV/EBITDA Ratio
--81.54-53.4270.90
Upgrade
EV/FCF Ratio
-22.62---572.04-
Upgrade
Debt / Equity Ratio
0.050.040.060.060.030.07
Upgrade
Debt / EBITDA Ratio
--1.245.920.521.00
Upgrade
Debt / FCF Ratio
----5.74-
Upgrade
Asset Turnover
0.390.370.350.290.320.28
Upgrade
Inventory Turnover
2.702.232.062.152.321.23
Upgrade
Quick Ratio
1.321.901.891.702.950.75
Upgrade
Current Ratio
1.782.402.202.043.231.05
Upgrade
Return on Equity (ROE)
-16.31%-7.73%-6.08%-7.60%-2.58%-0.23%
Upgrade
Return on Assets (ROA)
-7.25%-5.94%-2.92%-3.51%-1.07%-0.46%
Upgrade
Return on Capital (ROIC)
-8.73%-7.09%-3.62%-4.41%-1.41%-0.63%
Upgrade
Earnings Yield
-5.61%-2.42%-3.56%-5.49%-0.69%-0.05%
Upgrade
FCF Yield
-4.35%-2.40%-5.21%-5.40%0.15%-1.52%
Upgrade
Dividend Yield
--0.52%0.65%0.90%0.18%
Upgrade
Buyback Yield / Dilution
-0.08%-2.86%-0.04%-9.32%-3.74%-
Upgrade
Total Shareholder Return
--2.86%0.48%-8.67%-2.84%0.18%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.